MLchartDataset catalogue

Inqovi

Term · Oncology and biomedicine · MLC-T-ONC-004339

A combination of decitabine and cedazuridine used to treat adults with myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Decitabine stops cells from making DNA, which may help keep cancer cells from growing and may kill them. Cedazuridine prevents the breakdown of decitabine in the body, which may allow more cancer cells to be killed. Inqovi is a type of antimetabolite and a type of cytidine deaminase inhibitor. Also called decitabine and cedazuridine.

Table 1. Record
IdentifierMLC-T-ONC-004339
FieldOncology and biomedicine
Synonymsdecitabine and cedazuridine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004339",
  "term": "Inqovi",
  "field": "Oncology and biomedicine",
  "definition": "A combination of decitabine and cedazuridine used to treat adults with myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Decitabine stops cells from making DNA, which may help keep cancer cells from growing and may kill them. Cedazuridine prevents the breakdown of decitabine in the body, which may allow more cancer cells to be killed. Inqovi is a type of antimetabolite and a type of cytidine deaminase inhibitor. Also called decitabine and cedazuridine.",
  "synonyms": [
    "decitabine and cedazuridine"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/inqovi/"
}

Record 9,293 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.